These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 7624492)

  • 1. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.
    Neyens LG; Alpherts WC; Aldenkamp AP
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):411-9. PubMed ID: 7624492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of levetiracetam in the treatment of epilepsy.
    Leppik IE
    Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126
    [No Abstract]   [Full Text] [Related]  

  • 4. Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction.
    Sisodiya SM; Sander JW; Patsalos PN
    Epilepsy Res; 2002 Feb; 48(3):217-9. PubMed ID: 11904240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.
    López-Góngora M; Martínez-Domeño A; García C; Escartín A
    Epileptic Disord; 2008 Dec; 10(4):297-305. PubMed ID: 19017572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of levetiracetam in the treatment of epilepsy.
    Brodie MJ; French JA
    Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new antiepileptic drug.
    Shorvon SD; van Rijckevorsel K
    J Neurol Neurosurg Psychiatry; 2002 Apr; 72(4):426-9. PubMed ID: 11909894
    [No Abstract]   [Full Text] [Related]  

  • 8. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
    Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
    Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects.
    Rémi C; Lorenzl S; Vyhnalek B; Rastorfer K; Feddersen B
    J Pain Palliat Care Pharmacother; 2014 Dec; 28(4):371-7. PubMed ID: 25313924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term continuation of levetiracetam in patients with refractory epilepsy.
    Krakow K; Walker M; Otoul C; Sander JW
    Neurology; 2001 Jun; 56(12):1772-4. PubMed ID: 11425954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience of marketed Levetiracetam in an epilepsy clinic-a one year follow up study.
    Betts T; Yarrow H; Greenhill L; Barrett M
    Seizure; 2003 Apr; 12(3):136-40. PubMed ID: 12651077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J;
    Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam in refractory pediatric epilepsy.
    Wheless JW; Ng YT
    J Child Neurol; 2002 Jun; 17(6):413-5. PubMed ID: 12174960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of antiepileptic drugs on cognition.
    Aldenkamp AP
    Epilepsia; 2001; 42 Suppl 1():46-9, discussion 50-1. PubMed ID: 11422358
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence on ''the unrecognized epilepsy spectrum: the effects of levetiracetam on neuropsychological functioning in relation to subclinical spike production''.
    Duane DD
    J Child Neurol; 2009 Dec; 24(12):1578; author reply 1579. PubMed ID: 19955348
    [No Abstract]   [Full Text] [Related]  

  • 18. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Baruzzi A
    Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam in three cases of progressive myoclonus epilepsy.
    Papacostas S; Kkolou E; Papathanasiou E
    Pharm World Sci; 2007 Jun; 29(3):164-6. PubMed ID: 17242859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.